期刊文献+

复方肾炎片联合贝那普利治疗慢性肾小球肾炎的研究 被引量:9

Clinical study of Fufang Shenyan pill combined with benazepril in treating chronic nephritis
下载PDF
导出
摘要 目的观察复方肾炎片联合贝那普利治疗慢性肾炎蛋白尿的疗效。方法将58例肾功能正常的慢性肾炎患者分为贝那普利(ACEI组)和复方肾炎片联合贝那普利组(联合组),分别检测两组治疗前后24h尿蛋白定量、血压、血肌酐。结果治疗4个月后,联合组临床疗效总有效率(82.76%)显著高于贝那普利组(68.97%)(P<0.05),联合组的24h尿蛋白低于ACEI组(P<0.05),血压、血肌酐两组差异无统计学意义(P>0.05)。结论复方肾炎片联合贝那普利比单用贝那普利能更有效地降低慢性肾炎患者蛋白尿,且安全可靠。 Objective To observe the clinical effect of Fufang Shenyan pill combined with benazepril in the treatment proteinuria of chronic nephritis.Methods 58 patiens were randomly divided into two groups:ACEI group in which 29 patiens were treated by benazepril and combined group in which 29 patiens were treated by Fufang Shenyan pill combined with Benazepril,with a course of 4 months.The clinical effect,24-hour urinary protein,serum creatinine,blood pressure were observed.Results The total effective rate was 82.76% in combined group and 68.97% in ACEI group(P〈0.05),24-hour urinary protein of combined group was lower than of ACEI group(P〈0.05).The differences of serum creatinine,blood pressure between the two groups were not significant.Conclusion Fufang Shenyan pill combined with benazepril is more effective in reducing proteinuria of chronic nephritis than individual benazepril.
出处 《中国实用医药》 2009年第4期61-62,共2页 China Practical Medicine
关键词 慢性肾炎 蛋白尿 复方肾炎片 贝那普利 Chronic nephritis Urinary protein Fufang Shenyan pill Benazepril
  • 相关文献

参考文献1

二级参考文献11

  • 1Remuzzi G,Bertani T.The pathophysiology of progressive nephropathies[J].N EngI J Med,1998,339:1448~1456.
  • 2William JD,Coles GA.Proteinuria a direct cause of renal morbidity[J]?Kidney Int,1994,45:443~450.
  • 3Lewis EJ,Hunsicker LG,Bain RP,et al.The effect of Angiotensin-converting-enzyme inhibition on diabetic nephropathy[J].N EngI J Med,1993,329:1456~1462.
  • 4Morelli E,Loon N,Meyer T,et al.Effects of convertingenzyme inhibition on barrier function in diabetic glomerulopathy[J].Diabetes,1990,39:76~82.
  • 5Lufft V,Kliem V,Hamkens A,et al.Antiproteinuric efficacy of fosinopril after renal transplantation is determined by the extent of vascular and tubulointerstitial damage[J].Clin Transplant,1998,12:409~415.
  • 6Rudberg S,Aperia A,Freyschuss U,et al.Enalapril reduces microalbuminuria in young normotensive type 1 (insulindependent)diabetic patients irrespective of its hypotensive effect[J].Diabetologia,1990,33:470~476.
  • 7Ruggenenti P,Perna A,Gherardi G et al.Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephritic proteinuria[J].Lancet,1999,354:359~364.
  • 8Ruggenenti P,Perna A,Mosconi L,et al.Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinurine,non-diabetic nepropathy[J].Lancet,1997,394:1857~1863.
  • 9Peters H,Border WA,Noble NA.Targeting TGF-β overexpression in renal disease:Maximizing the antifibrotic action of angiotensin Ⅱ blockade[J].Kidney Int,1998,54:1570~1580.
  • 10Palla R,Pannichi V,Finato V,et al.Effect of increasing doses of lisinopril on proteinuria of normotensive patients with IgA nephropathy and normal renal function[J].Int J Clin Pharmacol Res,1994,14:35~43.

共引文献6

同被引文献72

引证文献9

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部